Publications by authors named "K B Naik"
Introduction: Zinc oxide nanoparticles (ZnONPs) have been the subject of substantial research by virtue of their utility across extensive downstream applications. Moreover, the ZnONPs are inexpensive, reliable, and easy to produce. Green synthesis employing biological systems, particularly plant extracts, has arisen as a subject of study in nanotechnology and is gaining importance due to its multiple applications in biology, chemistry, physics, and medicine.
View Article and Find Full Text PDFArticle Synopsis
- - A 66-year-old man experienced increasing exertional chest pain, quickly worsening from NYHA class 2 to class 3, prompting medical investigation despite the lack of a clear trigger.
- - ECG results indicated changes typical of Wellens' syndrome, usually linked to serious left anterior descending artery blockages, yet initial checks showed no significant atherosclerosis.
- - Advanced imaging techniques, including coronary angiography and cardiac CT, identified a severe myocardial bridge in the LAD artery, highlighting the need to consider congenital anomalies in cardiac diagnosis and the importance of early recognition for effective treatment.
Rationale: Early mortality in intracerebral haemorrhage (ICH) is due to haematoma volume (HV) expansion and there are no effective treatments available other than reduction in blood pressure. Tranexamic acid (TXA) a hemostatic drug which is widely available and safe can be a cost-effective treatment for ICH, if proven efficacious.
Hypothesis: Administration of TXA in ICH patients when given within 4.
Bilateral vocal cord paralysis in intermediate syndrome: a rare clinical presentation of organophosphorus poisoning.
Eur Arch Otorhinolaryngol
December 2024
Organophosphorus poisoning poses a significant health threat, often resulting in high mortality and disability. The intermediate syndrome, characterized by muscle weakness in neck flexors and limbs, is prevalent. While uncommon, cases of vocal cord paralysis have been observed.
View Article and Find Full Text PDFBackground: There is a paucity of data on treatment of osteoporosis in patients with advanced chronic kidney disease (CKD).
Objective: To assess the risk for emergently treated hypocalcemia with denosumab by stage of CKD and presence of CKD-mineral and bone disorder (CKD-MBD).
Design: Target trial emulation.